Colin is the managing director at Théa Open Innovation. Théa Open Innovation is a sister company of Laboratoires Théa, a European pharmaceutical company specialized in ophthalmology. The goal of Théa Open Innovation is to set up strategic alliances with universities, biotechs or pharma partners in order to bring to patients the ophthalmic products of tomorrow. Previously, Colin was the head of business development at Laboratoires Théa. He has a R&D background (INSERM, Sanofi, Laboratoires Servier and Laboratoires Théa). He is a biomedical engineer by training. Colin is a Board Member at AxeroVision; he is also the general manager of Sincler, a spin-off company of Laboratoires Théa.